PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8586009-0	1995	Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.	Enalapril	11-20	epidermal growth factor	Homo sapiens	58-81	
8586009-1	1995	OBJECTIVE: To compare the effect of the antihypertensive drugs nitrendipine and enalapril on the excretion of epidermal growth factor (EGF) and albumin in hypertensive non-insulin-dependent diabetes mellitus (NIDDM) subjects.	Enalapril	80-89	epidermal growth factor	Homo sapiens	110-133	
8586009-1	1995	OBJECTIVE: To compare the effect of the antihypertensive drugs nitrendipine and enalapril on the excretion of epidermal growth factor (EGF) and albumin in hypertensive non-insulin-dependent diabetes mellitus (NIDDM) subjects.	Enalapril	80-89	epidermal growth factor	Homo sapiens	135-138	
8586009-5	1995	In the enalapril group, EGF excretion progressively increased from 188 to 214 nmol/mmol creatinine after 6 weeks and to 274 after 8 months of therapy (P = 0.03).	Enalapril	7-16	epidermal growth factor	Homo sapiens	24-27	
8586009-8	1995	CONCLUSIONS: The angiotensin-converting enzyme inhibitor enalapril has been effective in decreasing albumin and increasing EGF excretion.	Enalapril	57-66	epidermal growth factor	Homo sapiens	123-126